Skip to main content
OpenTrials

Clinical trial condition

Gaucher Disease

Explore clinical trials studying Gaucher Disease. Study availability and eligibility vary by location and protocol.

131 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Gaucher Disease trial results

Completed

A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients

NCT00358150

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • New York University New York, United States
  • New York, United States
  • Aprillus Asistencia e Investigación Buenos Aires, Argentina
  • Hospital de Oncologia Maria Curie Buenos Aires, Argentina
View all 17 locations
View Trial Details
Completed

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

NCT01074944

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • University of California, San Diego Medical Center San Diego, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Emory University Medical Center Decatur, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 46 locations
View Trial Details
Completed

A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)

NCT00943111

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • UCSF MS Center San Francisco, California, United States
  • University of Colorado Health Science Center - Aurora Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
View all 34 locations
View Trial Details
Completed

Auto-antibodies Prevalence and CD1 Role in Gaucher Disease

NCT02650219

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Internal Medicine Department, Hôpital Minjoz, Besançon, France
  • Intensive Care Department, Hôpital Pellegrin, Bordeaux, France
  • Internal Medicine Department, Hôpital Beaujon, Clichy, France
  • Internal Medicine and Clinical Immunology Department, CHU, Dijon, France
View Trial Details
Completed

Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease

NCT00364858

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University Research Foundation for Lysosomal Storage Disease, Inc. Coral Springs, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 26 locations
View Trial Details

Related conditions